Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 50%Moderate 1 · 50%High 0 · 0%

Digital technology (TIM) vs standard treatment (TBM)

Adherence to inhaled therapies cMPR · children aged 5 to 16 years

Digital technology (TIM) may leads to higher adherence to the inhaled treatment: compared with standard treatment (TBM) (low certainty).

1 finding from 1 review

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
MD 24 [2.95, 45.05]
1 study · 20 participants
Low

Digital technology (web‐based platform CFHealthHub) vs usual care

Adherence to the inhaled treatment: percentage adherence · adults (aged 16 years and over) with CF

Digital technology (web‐based platform CFHealthHub) probably leads to higher adherence to the inhaled treatment: percentage adherence compared with usual care (moderate certainty).

1 finding from 1 review

Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis 2023 · Cochrane Headline outcomes only
MD 18 [12.9, 23.1]
1 study · 588 participants
Moderate